Pharmascience Inc. v. Meda AB et al - Nov 15, 2021 - Part 1

Sean Prouse1h 40min

MR. de SOUSA

32:45

The sitting of the federal court by videoconference is now open. Presiding, the Honorable Mr. Justice Zinn. Before the court, file T-815-17 between Pharmascience Inc. and Meda AB, Meda Pharmaceuticals Ltd., Valeant Canada LP and Valeant Canada SEC. Markus Klee, Jonathan Stainsby, Jonathan Giraldi, Aleem Abdulla and Yaseen Manan represent the Plaintiff. Melanie Baird, Andrew Skodyn, Cole Meagher, Rebecca Torrance and Sanjit Rajayer represent the Defendants.

JUSTICE ZINN

34:26

Good morning, counsel.

MR. KLEE

34:28

Good morning, Justice Zinn.

JUSTICE ZINN

34:30

Just a couple of small housekeeping matters. I did receive your compendium, Mr. Klee, for your opening statements this morning, just so you know. Obviously I haven't turned the pages of it, but I do have it in front of me. I have three screens going now. I have the transcript over here on my left, I have you folks directly in front of me and I have the eTrial Toolkit over on the side. If at any time you wish to use screen sharing to show a document either to the witness or to me, please just tell me that's what you're doing. You don't need to seek my permission time. You just got your blanket permission to do that. And because there is no confidentiality order in place, as documents are entered as exhibits any x and the confidential file on the E-trial toolkit, I've instructed the registrar to remove that. So it will be a public document. And with that, unless there's any issue that either of you feel we need to address before we get started, you can start with opening statements.

MR. KLEE

35:54

I have a -- thank you, Justice Zinn. And I have a couple of housekeeping matters as well that I'll just raise with the court. The first is the trial schedule. You should have a copy of that. That was sent in. That's the obviously the current list of witnesses and the order in which we believe they will appear there is an update to that that's currently being circulated among counsel and that will be provided to the court as soon as it's ready. Okay, thank you. We also have some documents that we'd like to begin by marking as exhibits. The first one is FC293. And that's the agreed facts between the parties.

Processing audio...